MedTech Dive December 4, 2023
Nick Paul Taylor

After gaining market share during the Philips recall, Resmed can keep growing by stimulating demand through marketing initiatives and new products, William Blair analysts wrote.

Dive Brief:

  • The leadership shakeup at Resmed could help the company meet and beat its growth targets by growing demand for its sleep apnea devices, according to William Blair analysts.
  • CEO Mick Farrell and other Resmed executives spoke to the analysts last week in meetings that left the William Blair team “more positive on the company’s strategy and ability to grow above market growth on the top line.”
  • The optimism is underpinned by a belief that Resmed, having increased its market share during the Philips recall, can continue to grow by mounting its...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article